Transmedix Corporation - 20850 Rockville, MD

Business Name: Transmedix Corporation
Categorized In: Commercial Biotechnical Research
Address: 9700 Great Seneca Highway # 188, Rockville, MD 20850
Phone Number: (240) 453-6347
Contact Person: Smelly AZHOLE
Business Type: B2B (Business to Business)
Founding Year: 2002
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Macrogen Clinical Laboratory Inc - Rockville, MD 20850
Clarassance Inc - Rockville, MD 20850
Cellomics Technology - Rockville, MD 20850
Immunomic Therapuetics Inc - Rockville, MD 20850
Precision Biologics - Rockville, MD 20850
Cybrdi Inc - Rockville, MD 20850
Medipost America Inc - Rockville, MD 20850
Mawi Dna Technologies - Rockville, MD 20850
Sigma Biosciences Corporation - Rockville, MD 20850
Mockv Solutions LLC - Rockville, MD 20850
Trophogen Inc - Rockville, MD 20850
Procell Corporation - Rockville, MD 20850
Cognition Therapeutics LLC - Rockville, MD 20850
Adlyfe Inc - Rockville, MD 20850
Cellphire Inc - Rockville, MD 20850
All American Protective Services LLC - Rockville, MD 20850
Genpromarkers Inc - Rockville, MD 20850
Omic Biosystems Inc - Rockville, MD 20850
Arraystar Inc - Rockville, MD 20850
Shuttle Pharmaceuticals LLC - Rockville, MD 20850

Transmedix Corporation provides professional Commercial Biotechnical Research from its single location at the coordinates 39.09759,-77.20398.

The company offers B2B variables under the SIC code and NAICS code , while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 2002, the company can now be visited at 9700 Great Seneca Highway # 188, Rockville, Maryland 20850 or contacted through representative Smelly AZHOLE at (240) 453-6347.

For frequently asked questions and further inquiries about professional Commercial Biotechnical Research, get to know more about Transmedix Corporation through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.